ETF Managers Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$5.96M	Buy	18,918 +16,194	+594%	+$4.86M	0.19%	95
2022 Q4	$787K	Sell	2,724 -2,847	-51%	-$868K	0.04%	193
2022 Q3	$1.61M	Sell	5,571 -663	-11%	-$191K	0.05%	168
2022 Q2	$1.75M	Buy	6,234 +3,000	+93%	+$803K	0.05%	176
2022 Q1	$830K	Buy	3,234 +56	+2%	+$13.3K	0.02%	334
2021 Q4	$707K	Buy	3,178 +150	+5%	+$29.2K	0.01%	429
2021 Q3	$552K	Buy	3,028 +234	+8%	+$45.7K	0.01%	512
2021 Q2	$550K	Buy	2,794 +1,455	+109%	+$304K	0.01%	522
2021 Q1	$285K	Buy	1,339 +175	+15%	+$38.4K	0.01%	593
2020 Q4	$271K	Sell	1,164 -1,457	-56%	-$334K	0.01%	560
2020 Q3	$708K	Sell	2,621 -1,092	-29%	-$301K	0.02%	252
2020 Q2	$1.06M	Buy	+3,713	New	+$1.01M	0.04%	174
2019 Q2	–	Sell	-877	Closed	-$161K	–	661
2019 Q1	$161K	Buy	877 +73	+9%	+$13.5K	0.01%	368
2018 Q4	$133K	Buy	804 +120	+18%	+$20.8K	0.01%	371
2018 Q3	$132K	Buy	684 +72	+12%	+$12.8K	0.01%	338
2018 Q2	$72	Sell	612 -30	-5%	-$4.65K	0.01%	341
2018 Q1	$100K	Buy	642 +80	+14%	+$13.1K	0.01%	282
2017 Q4	$86K	Buy	562 +80	+17%	+$11.8K	0.01%	263
2017 Q3	$73K	Buy	482 +40	+9%	+$6.02K	0.01%	158
2017 Q2	$57K	Buy	+442	New	+$53.2K	﹤0.01%	235
2016 Q1	$33K	Buy	+298	New	+$27K	0.02%	277